Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
The mother of a 21-year-old woman who died after taking potentially toxic diet pills has warned others to avoid using the drugs.
It's a case of mistaken identity as the actress is forced to differentiate himself from an Irish activist sharing her name
Jeffrey Okafor is accused of murdering 19-year-old Carl Beatson-Asiedu outside a nightclub in south London in 2009. His trial began today.